Genomed Spólka Akcyjna reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was PLN 4.75 million compared to PLN 4.58 million a year ago. Net income was PLN 0.213946 million compared to PLN 0.244163 million a year ago.
For the nine months, revenue was PLN 14.38 million compared to PLN 13.97 million a year ago. Net loss was PLN 0.176808 million compared to net income of PLN 0.30591 million a year ago.